Clinical Trials Logo

Clinical Trial Details — Status: Unknown status

Administrative data

NCT number NCT02117180
Other study ID # CdeK2014
Secondary ID
Status Unknown status
Phase Phase 1
First received April 9, 2014
Last updated June 3, 2015
Start date February 2014
Est. completion date August 2015

Study information

Verified date June 2015
Source University of Plymouth
Contact Claire de Koker, BSc (Hons)
Phone (+44)208 746 8173
Email claire.dekoker@chelwest.nhs.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot study aims to establish whether a low FODMAP diet is safe in children with functional gastrointestinal disorders. The practicality of implementing this diet will be evaluated as well as symptom improvement and quality of life. A larger intervention trial, if deemed appropriate, will then follow to assess symptom efficacy in children.


Recruitment information / eligibility

Status Unknown status
Enrollment 15
Est. completion date August 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender All
Age group 10 Years to 16 Years
Eligibility Inclusion Criteria:

- Patients aged 10-16 years

- Informed consent and assent obtained

- Patients with diagnosed FGID according to Rome III criteria: i.e. category H2b (irritable bowel syndrome) and H2d (childhood functional abdominal pain)

Exclusion Criteria:

- Patients with other gastrointestinal conditions (e.g. coeliac disease, inflammatory bowel disease)

- Patients with food allergies

- Patients with a weight for age below -2 Standard Deviations (SD) (below 0.4th centile) on the UK WHO growth charts.

- Patients with known micronutrient deficiencies determined by blood levels prior to study

- Patients without informed consent and assent obtained

Study Design


Related Conditions & MeSH terms


Intervention

Other:
FODMAP's diet
The safety and efficacy of a low FODMAP diet will be evaluated in a convenience sample of children with functional gastrointestinal disorders, over a 6 week intervention period.

Locations

Country Name City State
United Kingdom Chelsea and Westminster NHS Foundation Trust London

Sponsors (2)

Lead Sponsor Collaborator
Dr Anne Payne University of London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Energy and nutrient intake Energy and nutrient intake will be assessed using a 4-day estimated food diary at baseline and 6-weeks after dietary intervention. Comparison will be made between baseline and 6-week data and with United Kingdom (UK) Reference Nutrient Intakes. Baseline, 6 weeks
Secondary Practicality of the FODMAP diet; impact of diet on Functional Gastro-Intestinal .Disorders (FGID) symptoms and stools Practicality of the FODMAP diet will be evaluated using a standardised structured questionnaire.
The impact of a low FODMAP diet on FGID symptoms and stools will be assessed using a validated symptom questionnaire and the Bristol Stool Chart.
The impact of a low FODMAP diet on quality of life will be assessed using the Pediatric Quality of Life Inventory (PedsQL) Gastrointestinal Symptoms Module.
Baseline, 6 weeks
Secondary Anthropometry: weight and mid-arm circumference Anthropometric measurements will be taken at baseline and 6 weeks after dietary intervention. Comparison will be made between baseline and 6-week data for weight and mid upper arm circumference, as well as comparing both baseline and 6-week data to the UK-WHO growth standards. Baseline, 6 weeks